Respective Title / Area of Specialization / Responsibilities | Date |
GCP training | 2005 |
Sub – investigator/Clinical trial (4) Wyeth, | 2005-2006 |
Sub – investigator/Clinical trial Therevance, | 2005-2007 |
Sub – investigator/Clinical trial Cerexa | 2005-2007 |
GCP training – 2 times | 2005-2007 |
Sub – investigator – MOA-728 protocol: 3200L2-300-WW | 2006-2007 |
Sub – investigator – MOA-728 protocol: 3200L2-301-WW | 2007 |
Investigator/Clinical trial ialuset gausepad protocol: 06F/iacp04 Crom | 2009 |
Investigator/Clinical trial Budesonid-MMX protocol:CB-01-02/02 Cosmo | 2009 |
Principal Coordinator/Clinical trial ialuset/Duoderm protocol: 08INT/iacp01 Crom | 2009/2010 |
Principal Investigator/Clinical trial Dermagen protocol: 06FB/DE02 Crom | 2009/2010 |
Principal Investigator/Clinical trial SULODEXIDE protokol: VTE/01/09 Alfa Wassermann/Crom | 2010/2011 |
Sub – investigator – CD, protocol: NN8555-3797/2011 Novo Nordisk | 2010 |
Investigator/Clinical trial Pes Diabetica protocol: TFM-CL3-002 | 2011 |
GCP training – 2 times | 2011 |
Sub – investigator – CU, protocol: LX1606.1-204-UC/2010 Lexicon | 2011 |
Sub – investigator – CU, protocol: KPT4-01/2011 Dr A.Wolff | 2011 |
Principal Investigator/Clinical trial protokol: NRL001-01/2011 (SEFI) Premier Research | 2012-2014 |
Principal Investigator/Clinical trial protocol: VEN307-AF-001 ClinMed Pharma | 2013-2014 |